Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
about
Immune recruitment and therapeutic synergy: keys to optimizing oncolytic viral therapy?Tumor Therapy Applying Membrane-bound Form of Cytokines.IL-12 and IL-27 sequential gene therapy via intramuscular electroporation delivery for eliminating distal aggressive tumors.Strategy of liver-directed gene therapy: present status and future prospects.Challenges and developing solutions for increasing the benefits of IL-2 treatment in tumor therapy.Lymphokines post autologous peripheral blood stem cell transplantation in children.Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.Local expression of antiinflammatory cytokines in cancerIntratumoral injection of an adenovirus expressing interleukin 2 induces regression and immunity in a murine breast cancer modelSynergy between T-cell immunity and inhibition of paracrine stimulation causes tumor rejection.Reversal of acute myelogenous leukemia in humanized SCID mice using a novel adoptive transfer approachVaccination with irradiated tumor cells engineered to secrete murine granulocyte-macrophage colony-stimulating factor stimulates potent, specific, and long-lasting anti-tumor immunity.Cancer vaccines: the interleukin 2 dosage effectGenetically modified tumour vaccines: an obstacle race to break host tolerance to cancer.Combination gene therapy for liver metastasis of colon carcinoma in vivoIn vivo cytokine gene transfer by gene gun reduces tumor growth in miceImmunomodulatory gene therapy for haematological malignancies.Cellular requirements for tumor-specific immunity elicited by heat shock proteins: tumor rejection antigen gp96 primes CD8+ T cells in vivo.Trying to overcome residual disease after bone marrow transplantation for hematologic malignancies.A brief history of gene therapy.Approaches to gene therapy of complex multigenic diseases: cancer as a model and implications for cardiovascular disease and diabetes.IL2 treatment for cancer: from biology to gene therapyGene therapy for carcinoma of the breast.Concepts and strategies for human gene therapy.Gene transfer approaches in cancer immunotherapy.Human cancer gene therapy with cytokine gene-modified cells.Chemokine gene transfection into tumour cells reduced tumorigenicity in nude mice in association with neutrophilic infiltration.The effect of combined expression of interleukin 2 and interleukin 4 on the tumorigenicity and treatment of B16F10 melanoma.Analysis of IL-2 receptor expression and of the biological effects of IL-2 gene transfection in small-cell lung cancerVaccines in cancer: GVAX, a GM-CSF gene vaccine.Mechanisms of rejection induced by tumor cell-targeted gene transfer of interleukin 2, interleukin 4, interleukin 7, tumor necrosis factor, or interferon gammaInterleukin 7 induces CD4+ T cell-dependent tumor rejection.Cytokine secretion by genetically modified nonimmunogenic murine fibrosarcoma. Tumor inhibition by IL-2 but not tumor necrosis factorCTLA-4 blockade synergizes with tumor-derived granulocyte-macrophage colony-stimulating factor for treatment of an experimental mammary carcinoma.Immunotherapy and skin cancer.Immunotherapy of malignancy by in vivo gene transfer into tumors.Dendritic cells as adjuvants for class I major histocompatibility complex-restricted antitumor immunity.Innate NKT lymphocytes confer superior adaptive immunity via tumor-capturing dendritic cells.Transduction of human hepatocellular carcinoma cells with human alpha-interferon gene via retroviral vectorPhase I clinical trial with IL-2-transfected xenogeneic cells administered in subcutaneous metastatic tumours: clinical and immunological findings.
P2860
Q24596171-8EA56768-E6FF-425E-B3D3-842761DBC935Q33631960-9ABBFC3C-7A58-4EA5-8C5C-C49C55BBBD1DQ33670036-58C49E2D-A8FF-4BEA-900C-EB807E779BA7Q33718826-79022C4E-9436-4CE4-BC78-C8A876D3BE1BQ33811204-14AC127C-F48B-4547-A65F-F0830E31255DQ33847106-BCB2DCDF-B925-49C6-AFDA-9D2B93E2492EQ33854375-60D526BC-4414-44D5-A7F6-509A24B77016Q33893313-0F52ED40-DB68-4A52-BBCE-D793C9C40644Q33989165-763ECCCE-9BC3-452A-A795-57C9259CE3B8Q34110762-664AE4BF-2629-42AE-9731-213B4A23BC29Q34183838-D0A78C83-CAEC-4E9F-9AFC-AFC5252A097AQ34334817-AB62C9F2-FAC5-4278-BC41-7421792B8F92Q34361454-77252F7D-830C-4FD6-BDCF-AF05D22B3BD0Q34452039-2B63593B-618C-475A-990C-CB70C598956BQ34480736-0DD9F5C0-8A42-4BC3-8DBE-4823C2EF0B89Q34513704-4DE7674F-A675-4784-8827-7B7CE38FC7DAQ34579664-7764EAF2-9ED4-4458-8BF5-F1D01CC2B5C7Q35154049-36215627-6C67-41D8-ABDA-C34A7049BADEQ35169842-28C75DC0-3AFD-49AF-B881-5930B3F08A92Q35222291-7DF03B82-9621-4823-BCA4-A85BFABA08C9Q35454954-88F11689-0787-48B7-B8FF-8BA262EA307EQ35565971-7A478ED8-46A8-41F7-90EF-F3748BDA56A8Q35609061-6EBE81C3-CA34-4ED7-BA98-C55A3471716AQ35816188-12D70B3C-D3C9-46E0-9240-F53F12C7EABDQ35904413-8F8F2888-7A22-40F1-965E-870E8F1189E3Q35907018-287BF85D-A7B2-477C-8788-C42015FC1050Q36081142-4192C01B-06A1-4928-9BBC-414121C87946Q36135662-8DAF37BE-D133-4AAD-BD51-A849693B7311Q36136052-1CCE348B-7FDF-4B43-B7B4-DF88DCA32ED2Q36198632-FEC5C2B1-1E4F-4FC1-94F0-1DF8580D6DE4Q36199032-FD8071CD-B785-4A81-9342-F7F54AC1858EQ36230708-75DECF40-ACDA-4F10-B616-E5E414075301Q36238330-F761526C-BE27-42DE-9ED6-E014AD368D20Q36284594-2C41B51B-8191-4D19-B3BC-90998C073D8AQ36295687-E39295DD-4DEE-4ACD-B6EA-2BCD227D9D92Q36309790-1EF6E47E-3DD3-4DFB-A9EC-0CF6779D4D04Q36366130-AC0740A0-B86A-49FA-AAB6-913BAB2E93BDQ36404025-4A588693-D8D7-4DCC-9767-8343177DE744Q36491780-4E066476-368E-4F68-A317-43550BCD5EA1Q36621492-DE1ABA28-17D9-4F8F-9A09-4457FF907938
P2860
Interleukin 2 gene transfer into tumor cells abrogates tumorigenicity and induces protective immunity.
description
1990 nî lūn-bûn
@nan
1990年の論文
@ja
1990年論文
@yue
1990年論文
@zh-hant
1990年論文
@zh-hk
1990年論文
@zh-mo
1990年論文
@zh-tw
1990年论文
@wuu
1990年论文
@zh
1990年论文
@zh-cn
name
Interleukin 2 gene transfer in ...... d induces protective immunity.
@en
type
label
Interleukin 2 gene transfer in ...... d induces protective immunity.
@en
prefLabel
Interleukin 2 gene transfer in ...... d induces protective immunity.
@en
P2093
P2860
P356
P1476
Interleukin 2 gene transfer in ...... d induces protective immunity.
@en
P2093
P2860
P304
P356
10.1084/JEM.172.4.1217
P407
P577
1990-10-01T00:00:00Z